Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Shop Apotheke Europe N.V.    SAE   NL0012044747

SHOP APOTHEKE EUROPE N.V.

(SAE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Shop Apotheke Europe N.V. : No turn-around in sight

share with twitter share with LinkedIn share with facebook
share via e-mail
05/22/2020 | 11:54am EDT
long trade
Live
Entry price : 100.2€ | Target : 119€ | Stop-loss : 83€ | Potential : 18.76%
Shop Apotheke Europe N.V.'s shares display attractive technical aspects to anticipate a comeback of the underlying trend.
Investors have an opportunity to buy the stock and target the € 119.
Shop Apotheke Europe N.V. : Shop Apotheke Europe N.V. : No turn-around in sight
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

Strengths
  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Sales forecast by analysts have been recently revised upwards.
  • For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 51.8 EUR

Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at EUR 97.86.
  • The company has insufficient levels of profitability.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The group usually releases earnings worse than estimated.
Ratings chart
Subsector Drug Retailers - NEC
1st jan.Capitalisation (M$)Investor Rating
SHOP APOTHEKE EUROPE N.V.113.10%1 504
-
WALGREENS BOOTS ALLIANCE, I..-26.56%37 984
MCKESSON CORPORATION14.91%25 725
CARDINAL HEALTH, INC.8.15%15 972
WELCIA HOLDINGS CO., LTD.28.63%8 677
SINOPHARM GROUP CO., LTD.-30.69%7 934
SHANGHAI PHARMACEUTICALS HO..-1.80%6 340
DASHENLIN PHARMACEUTICAL GR..56.90%6 292
YIFENG PHARMACY CHAIN CO., ..53.61%5 980
HUADONG MEDICINE CO., LTD-6.44%5 600
JOINTOWN PHARMACEUTICAL GRO..29.12%4 702
More Results

Nicolas Aleksy
© MarketScreener.com 2020
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials
Sales 2020 898 M 1 000 M 1 000 M
Net income 2020 -16,9 M -18,8 M -18,8 M
Net Debt 2020 32,9 M 36,6 M 36,6 M
P/E ratio 2020 -77,1x
Yield 2020 -
Capitalization 1 352 M 1 504 M 1 504 M
EV / Sales 2019
EV / Sales 2020 1,54x
Nbr of Employees 1 011
Free-Float 97,2%
Upcoming event on SHOP APOTHEKE EUROPE N.V.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Average target price 111,88 €
Last Close Price 92,70 €
Spread / Highest target 51,0%
Spread / Average Target 20,7%
Spread / Lowest Target -8,31%
EPS Revisions
Managers
NameTitle
Stefan Feltens Chief Executive Officer
Jan Pyttel Chairman-Supervisory Board
Theresa Holler Chief Operating Officer
Jasper Eenhorst Chief Financial Officer
Marc Fischer Chief Technical Officer